| 15:00 - 15:10 | Welcome address Dr Stelios Kympouropoulos, MEP |
| 15:10 – 15:25 | The State of the ATMP sector in Europe Tim Hunt, Chief Executive Officer, Alliance for Regenerative Medicine |
| 15:25 – 15:40 | Testimonial from the first pediatric patient cured with CAR-T therapy Emily Whitehead & Tom Whitehead, Emily Whitehead Foundation |
| 15:40 – 15:55 | EU initiatives of relevance to the ATMP sector Sylvain Giraud, Head of Unit ‘Medical Products: Quality, Safety, Innovation’, DG Sante, European Commission |
| 15:55 – 16:55 | Panel discussion: How to improve patient access to ATMPs in Europe? Patrick Celis, Scientific Administrator, Committee for Advanced Therapies, European Medicines Agency Lucy Ellerker, Patient Advocate Simone Boselli, Director of Public Affairs, EURORDIS Rare Disease Europe Susana Solís Perez, MEP Chris Vann, Chief Operating Officer at Autolus, and Member of the Alliance for Regenerative Medicine’s Board |
| 16:55 – 17:00 | Concluding remarks Dr Miguel Forte, President-Elect of the International Society for Cell & Gene Therapy, and Member of the Alliance for Regenerative Medicine’s Board |